Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516472 · ClinicalTrials.gov registry record · Early Phase 1
Fecal Microbiota Transplantation in Kidney Stone Patients
A Early Phase 1 study of Kidney Stones, sponsored by Joshua Stern.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05516472 is a Early Phase 1 study of Kidney Stones that is actively recruiting participants, run by Joshua Stern. The registered enrollment target is 36 participants, below the 292-participant average among 15 other Kidney Stones trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05516472, a Early Phase 1 study of Kidney Stones, is actively recruiting participants, sponsored by Joshua Stern.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure the impact of Microbial Transplant Therapy (MTT) on 24-hour urine parameters in recurrent hypercalciuric and hyperoxaluric kidney stone formers.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Microbial Transplant Therapy
Study Locations (1)
Utah
- Park City Hospital - Park City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-10-10 |
| Est. Completion | 2027-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05516472
The ClinicalTrials.gov registry entry for NCT05516472 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 15 other Kidney Stones trials with a reported enrollment target (88% lower). The listed sponsor is Joshua Stern, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Stones appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05516472 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05516472 about?
NCT05516472 is a clinical study titled "Fecal Microbiota Transplantation in Kidney Stone Patients". The purpose of this study is to measure the impact of Microbial Transplant Therapy (MTT) on 24-hour urine parameters in recurrent hypercalciuric and hyperoxaluric kidney stone formers.
What is the current status of trial NCT05516472?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 36 participants. The study started on 2024-10-10. Estimated completion is 2027-03.
What conditions does trial NCT05516472 study?
This clinical trial studies the following conditions: Kidney Stones.
What interventions are being tested in trial NCT05516472?
The interventions under investigation include: Placebo (DRUG), Microbial Transplant Therapy (DRUG).
Who is sponsoring clinical trial NCT05516472?
This trial is sponsored by Joshua Stern, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05516472 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stones
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SGLT2i in Kidney Stones
RECRUITING · Early Phase 1
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Evaluation of Eye Gaze Sharing in the Operating Room
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
CaOx Stone Prevention
RECRUITING · Phase 4
-
Eye Gaze Guidance Evaluation in Phantoms
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.